Parameters | Successful cases (n = 290) | Failed cases (n = 10) | P value |
---|---|---|---|
Age (years) | 43.78 ± 12.74 | 48.10 ± 11.93 | 0.2917 |
Male/Female, n | 72/218 | 1/9 | 0.4603 |
Body weight (kg) | 62.39 ± 10.76 | 58.35 ± 8.11 | 0.2409 |
Body mass index (kg m−2) | 23.46 ± 3.32 | 22.75 ± 3.41 | 0.5070 |
ASA status, n (%) | 0.8467 | ||
Class 1 | 136 (46.9%) | 5 (50%) | |
Class 2 | 154 (53.1%) | 5 (50%) | |
Mallampati Classification, n(%) | 0.3896 | ||
1 | 135 (46.55%) | 3 (30%) | |
2 | 142 (48.97%) | 7 (70%) | |
3 | 13 (4.48%) | 0 | |
Type of Surgery, n (%) | 0.7955 | ||
Gallbladder surgery | 94 (32.41%) | 3 (30%) | |
Gynecology | 147 (50.69%) | 6 (60%) | |
General surgery | 49 (16.9%) | 1 (10%) | |
Position of the patients, n (%) | 0.9632 | ||
Supine position | 23 (7.93%) | 1 (10%) | |
Reverse-Trendelenburg position | 95 (32.76%) | 3 (30%) | |
Trendelenburg position | 172 (59.31%) | 6 (60%) | |
Duration of Surgery (min) | 81.14 ± 41.30 | – | |
Total dosage of neuromuscular blockade (mg) | 0.8840 | ||
Rocuronium | 48.62 ± 13.26 | 48.33 ± 16.02 | |
Cisatracurium | 14.82 ± 5.17 | 13.5 ± 1.66 |